GDT is a pure utility token directly tied to real-world services such as curative diabetes tourism, biomarker testing, and specialist consultations. Unlike speculative tokens, it is backed by a scientific project targeting complete remission of diabetes through HDAC inhibitors, 5-ALA, and Biozipcode™ drug delivery technology. It is not a security and offers no dividends or ownership rights.